LLMs are advancing at an alarming speed, and depending on your stance, that's either apocalyptic or fantastic. AI agents are all the hype nowadays, but any agent is ultimately limited by the model ...

Scientists at the Institute of Cancer Research in London are contributing to an international clinical trial evaluating THEO-260, an experimental oncolytic immunotherapy designed to treat ...